Aging and Cardiovascular Disease: Current Status and Challenges

Aging and Cardiovascular Disease: Current Status and Challenges

Cardiovascular disease (CVD) is the leading cause of death worldwide. Population aging is becoming the most important driver of the CVD epidemic. With the rapid increase in an aging population, the burden of CVD will continuously increase. Most old people also suffer multimorbidity, which is strongl...

Full description

Bibliographic Details
Main Authors:	Mengge Zhou, Guanqi Zhao, Yuhong Zeng, Jiming Zhu, Feng Cheng, Wannian Liang
Format:	Article
Language:	English
Published:	IMR Press 2022-04-01
Series:	Reviews in Cardiovascular Medicine
Subjects:	aging cardiovascular disease epidemiology multimorbidity deprescribing
Online Access:	https://www.imrpress.com/journal/RCM/23/4/10.31083/j.rcm2304135

Similar Items

The health impacts of preventive cardiovascular medication reduction on older populations: protocol for a systematic review and meta-analysis
by: Rik S. van der Veen, et al.
Published: (2021-06-01)

The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial
by: E. A. Bayliss, et al.
Published: (2020-06-01)

How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
by: Sophie Mantelli, et al.
Published: (2018-10-01)

Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective
by: Salvatore Crisafulli, et al.
Published: (2022-12-01)

Person-Centred Care Including Deprescribing for Older People
by: Heather Smith, et al.
Published: (2019-07-01)

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
by: Lykke I. Kaas Oldenburg, et al.
Published: (2022-03-01)

General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries
by: Katharina Tabea Jungo, et al.
Published: (2021-01-01)

Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials
by: Salvatore Crisafulli, et al.
Published: (2021-10-01)

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis
by: Joanne Reeve, et al.
Published: (2022-07-01)

Patient-provider concordance in the perception of illness and disease: a cross-sectional study among multimorbid patients and their general practitioners in Switzerland
by: Neuner-Jehle S, et al.
Published: (2017-08-01)

Healthy aging and cardiovascular health in Kyrgyzstan: current status and emerging challenges
by: Stefano Cacciatore, et al.
Published: (2024-02-01)

Influence of chronic medical conditions on older patients’ willingness to deprescribe medications: a cross-sectional study
by: Anabela Pereira, et al.
Published: (2024-04-01)

The evolution of polypharmacy: appropriate and problematic polypharmacy, choosing the right strategy and tactics
by: M. V. Leonova
Published: (2021-10-01)

Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: Process evaluation of the SPPiRE trial
by: Caroline McCarthy, et al.
Published: (2022-12-01)

The role of older patients’ goals in GP decision-making about medicines: a qualitative study
by: Kristie Rebecca Weir, et al.
Published: (2021-01-01)

Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial
by: Dee Mangin, et al.
Published: (2021-10-01)

What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey
by: Zsofia Rozsnyai, et al.
Published: (2020-10-01)

A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial
by: Anissa Aharaz, et al.
Published: (2021-03-01)

Improving inappropriate medication and information transfer at hospital discharge: study protocol for a cluster RCT
by: Thomas Grischott, et al.
Published: (2018-12-01)

Barriers and facilitators to deprescribing in primary care: a systematic review
by: Alison Jayne Doherty, et al.
Published: (2020-07-01)

The extent and burden of high multimorbidity on older adults in the US: a descriptive analysis of Medicare beneficiaries
by: David A. Dorr, et al.
Published: (2024-09-01)

Older people’s attitudes towards deprescribing cardiometabolic medication
by: Stijn Crutzen, et al.
Published: (2021-06-01)

Spectrum of cardiovascular diseases with increasing age and its association with geriatric syndromes
by: Pramod Kumar, et al.
Published: (2022-01-01)

Main and moderated effects of multimorbidity and depressive symptoms on cognition
by: Jacyra Azevedo Paiva de Araujo, et al.
Published: (2022-09-01)

(De)Prescribing of proton pump inhibitors: what has changed in recent years? an observational regional study from the French health insurance database
by: Pauline Gendre, et al.
Published: (2022-12-01)

Evaluation of deprescription by general practitioners in elderly people with different levels of dependence: cross-sectional study
by: Tânia Coelho, et al.
Published: (2024-03-01)

Cardiovascular Disease Multimorbidity and Decreased Health‐Related Quality of Life in Haiti: A Cross‐Sectional Study
by: Shalom Sabwa, et al.
Published: (2025-02-01)

Multimorbidity status and risk factors among adults aged 45-64 years in 15 provinces of China in 2018: Based on association rule analysis
by: Zhiru WANG, et al.
Published: (2024-07-01)

Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence
by: Jonathan Pearson-Stuttard, et al.
Published: (2022-10-01)

Associations among socioeconomic status, multimorbidity of non-communicable diseases, and the risk of household catastrophic health expenditure in China: a population-based cohort study
by: Yaping Wang, et al.
Published: (2023-04-01)

Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study
by: Noemí Villén, et al.
Published: (2020-06-01)

Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study
by: François-Xavier Sibille, et al.
Published: (2022-02-01)

Student Perspectives on the Pharmacist’s Role in Deprescribing Opioids: A Qualitative Study
by: Alina Cernasev, et al.
Published: (2023-07-01)

The burden of polypharmacy and potentially inappropriate medication in Nigeria: a clarion call for deprescribing practice
by: Safiya Bala Borodo, et al.
Published: (2022-06-01)

Prevalence and pattern of multimorbidity in China: a cross-sectional study of 224,142 adults over 60 years old
by: Xing Hu, et al.
Published: (2024-07-01)

Deprescribing potential of commonly used medications among community-dwelling older adults: insights from a pharmacist’s geriatric assessment
by: Iva Bužančić, et al.
Published: (2024-03-01)

Hypertension and Drug Adherence in the Elderly
by: Michel Burnier, et al.
Published: (2020-04-01)

Cardiovascular diseases in China: Current status and future perspectives
by: Hua Li, et al.
Published: (2015-03-01)

Polypharmacy is a challenge for our generation, and the knowledge of deprescribing is a needed skill of our health care professionals
by: Shadi Sarahroodi
Published: (2022-04-01)

Associations of Sleep Patterns With Dynamic Trajectory of Cardiovascular Multimorbidity and Mortality: A Multistate Analysis of a Large Cohort
by: Jingyi Zhang, et al.
Published: (2023-10-01)